These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22690072)

  • 1. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition.
    Zhou HM; Dong TT; Wang LL; Feng B; Zhao HC; Fan XK; Zheng MH
    World J Gastroenterol; 2012 Jun; 18(21):2640-8. PubMed ID: 22690072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines.
    Dong TT; Zhou HM; Wang LL; Feng B; Lv B; Zheng MH
    Ann Surg Oncol; 2011 Jun; 18(6):1797-804. PubMed ID: 21267784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
    Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
    Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
    Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.
    Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G
    Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line.
    Saltanatpour Z; Johari B; Alizadeh A; Lotfinia M; Majidzadeh-A K; Nikbin B; Kadivar M
    J Cell Physiol; 2019 Dec; 234(12):22935-22946. PubMed ID: 31111504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological significance of tumor budding at the invasive front of human colorectal carcinoma cells.
    Yusra ; Semba S; Yokozaki H
    Int J Oncol; 2012 Jul; 41(1):201-10. PubMed ID: 22569829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMAL1 Knockdown Leans Epithelial-Mesenchymal Balance toward Epithelial Properties and Decreases the Chemoresistance of Colon Carcinoma Cells.
    Zhang Y; Devocelle A; Desterke C; de Souza LEB; Hadadi É; Acloque H; Foudi A; Xiang Y; Ballesta A; Chang Y; Giron-Michel J
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CD133 promotes the invasion and metastasis of gastric cancer via epithelial-mesenchymal transition].
    Cai C; Yu JW; Wu JG; Lu RQ; Ni XC; Wang SL; Jiang BJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jul; 16(7):662-7. PubMed ID: 23888452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination effect of Prominin1 (CD133) suppression and Oxaliplatin treatment in colorectal cancer therapy.
    Asadzadeh Z; Mansoori B; Mohammadi A; Kazemi T; Mokhtarzadeh A; Shanehbandi D; Hemmat N; Derakhshani A; Brunetti O; Safaei S; Aghajani M; Najafi S; Silvestris N; Baradaran B
    Biomed Pharmacother; 2021 May; 137():111364. PubMed ID: 33592546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell lines.
    Skarkova V; Skarka A; Manethova M; Stefanidi AA; Rudolf E
    Hum Exp Toxicol; 2021 Dec; 40(12):2063-2073. PubMed ID: 34075792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF-
    Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q
    Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Cyanidin-3-
    Kurter H; Basbinar Y; Ellidokuz H; Calibasi-Kocal G
    Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of Poria cocos combined with oxaliplatin on the inhibition of epithelial-mesenchymal transition in gastric cancer cells.
    Wang N; Liu D; Guo J; Sun Y; Guo T; Zhu X
    Biomed Pharmacother; 2018 Jun; 102():865-873. PubMed ID: 29710543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Claudin-7 downregulation induces metastasis and invasion in colorectal cancer via the promotion of epithelial-mesenchymal transition.
    Wang K; Li T; Xu C; Ding Y; Li W; Ding L
    Biochem Biophys Res Commun; 2019 Jan; 508(3):797-804. PubMed ID: 30528239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
    Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
    World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
    Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
    Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLLT10 promotes tumor migration, invasion, and metastasis in human colorectal cancer.
    Jing X; Wu H; Cheng X; Chen X; Zhang Y; Shi M; Zhang T; Wang X; Zhao R
    Scand J Gastroenterol; 2018 Aug; 53(8):964-971. PubMed ID: 30102091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.